Zelquistinel in the Treatment of Major Depressive Disorder

NCT03586427 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

251

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: AGN-241751
DRUG: Placebo

Sponsor

Syndeio Biosciences, Inc